NOS2 and pulmonary emphysema: In agreement with our findings, Theodoro-Junior et al. (2017) demonstrated in an emphysema model that an EcTI inhibitor mitigated oxidative stress, leading to decreased cellular expression of eNO and iNOS in both the alveolar septa and airway pathways.